“…In eyes that show diffuse oozing, laser photocoagulation may not be a suitable treatment modality because localization of the leaking point is difficult. Photodynamic therapy (PDT) with verteporfin, which causes less thermal damage, has resulted in beneficial visual outcomes in most studies of patients with chronic CSC [5][6][7]. However, several studies have shown that conventional PDT, traditionally used to treat choroidal neovascularization or polypoidal choroidal vasculopathy, may cause RPE atrophy, choroidal ischemia, and transient reduction in macular function [5,8,9].…”